2021 annual financial data
UroGen Pharma 2021 Operating margin
Direct answer
Operating margin was -192.11%.
Operating income was -92,292,000 USD and net income was -110,820,000 USD.
Operating cash flow was -84,892,000 USD.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 48,042,000 USD
- Operating income
- -92,292,000 USD
- Net income
- -110,820,000 USD
- Operating cash flow
- -84,892,000 USD